Literature DB >> 16234237

C-terminal p73 isoforms repress transcriptional activity of the human telomerase reverse transcriptase (hTERT) promoter.

Tomás Racek1, Nikica Mise, Zhenpeng Li, Anja Stoll, Brigitte M Pützer.   

Abstract

Activation of telomerase is linked to tumorigenesis and has been observed in a variety of human tumors. Previous reports demonstrated that p53 represses human telomerase reverse transcriptase (hTERT), a key component for telomerase activity. The p73 protein displays a tumor suppressor activity similar to p53. In the present study, we examined the effect of transactivation competent p73 isoforms on hTERT expression in p53-negative human H1299 cells. Overexpression of C-terminal p73 isoforms (alpha, beta, gamma, delta) resulted in a clear down-regulation of hTERT promoter activity. The strongest inhibitory effect, comparable with p53, was observed for p73beta. Moreover, suppression of hTERT expression was also mediated by endogenous p73 after activation of E2F1 in H1299ER-E2F1 cells. Mutations in the Sp1 transcription factor-binding sites of the proximal core promoter region significantly abolished p73-induced repression, suggesting that the effect is mediated by Sp1. Finally, we demonstrate that p73 directly interacts with Sp1, suggesting that formation of a p73-Sp1 complex is the underlying mechanism for p73-triggered inhibition of hTERT expression. Our findings provide additional evidence that p73 mimics p53 in many aspects in cells lacking functional p53, thereby contributing to tumor surveillance.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16234237     DOI: 10.1074/jbc.C500193200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

Review 1.  Tumor suppression by p53: making cells senescent.

Authors:  Yingjuan Qian; Xinbin Chen
Journal:  Histol Histopathol       Date:  2010-04       Impact factor: 2.303

Review 2.  A balancing act: orchestrating amino-truncated and full-length p73 variants as decisive factors in cancer progression.

Authors:  D Engelmann; C Meier; V Alla; B M Pützer
Journal:  Oncogene       Date:  2014-11-10       Impact factor: 9.867

3.  An unbiased in vivo screen reveals multiple transcription factors that control HPV E6-regulated hTERT in keratinocytes.

Authors:  Mei Xu; Rachel A Katzenellenbogen; Carla Grandori; Denise A Galloway
Journal:  Virology       Date:  2013-08-08       Impact factor: 3.616

4.  NFX1-123 and poly(A) binding proteins synergistically augment activation of telomerase in human papillomavirus type 16 E6-expressing cells.

Authors:  Rachel A Katzenellenbogen; Erin M Egelkrout; Portia Vliet-Gregg; Lindy C Gewin; Philip R Gafken; Denise A Galloway
Journal:  J Virol       Date:  2007-01-31       Impact factor: 5.103

5.  Tumor suppressors p53, p63TAα, p63TAy, p73α, and p73β use distinct pathways to repress telomerase expression.

Authors:  Yuan Yao; Marcia Bellon; Shary N Shelton; Christophe Nicot
Journal:  J Biol Chem       Date:  2012-04-10       Impact factor: 5.157

6.  PML involvement in the p73-mediated E1A-induced suppression of EGFR and induction of apoptosis in head and neck cancers.

Authors:  P Klanrit; P Taebunpakul; M B Flinterman; E W Odell; M A Riaz; G Melino; P Salomoni; J S Mymryk; J Gäken; F Farzaneh; M Tavassoli
Journal:  Oncogene       Date:  2009-07-13       Impact factor: 9.867

7.  Association of hsp90 to the hTERT promoter is necessary for hTERT expression in human oral cancer cells.

Authors:  Reuben H Kim; Roy Kim; Wei Chen; Shen Hu; Ki-Hyuk Shin; No-Hee Park; Mo K Kang
Journal:  Carcinogenesis       Date:  2008-09-26       Impact factor: 4.944

8.  Sp1 and p73 activate PUMA following serum starvation.

Authors:  Lihua Ming; Tsukasa Sakaida; Wen Yue; Anupma Jha; Lin Zhang; Jian Yu
Journal:  Carcinogenesis       Date:  2008-06-25       Impact factor: 4.944

9.  The regulation of telomerase in oncogenesis.

Authors:  D A Skvortzov; M P Rubzova; M E Zvereva; F L Kiselev; O A Donzova
Journal:  Acta Naturae       Date:  2009-04       Impact factor: 1.845

Review 10.  Telomerase as a useful target in cancer fighting-the breast cancer case.

Authors:  Hanna Holysz; Natalia Lipinska; Anna Paszel-Jaworska; Blazej Rubis
Journal:  Tumour Biol       Date:  2013-04-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.